The Prognostic Value of the Inflammation-Immunity-Nutrition Score in Advanced Non-Small Cell Lung Cancer Undergoing First-Line Immunotherapy: A 3-Year Retrospective Cohort Study
OBJECTIVE: This study preliminarily evaluated the prognostic value of the inflammation-immunity-nutrition score (IINS) in advanced NSCLC patients receiving first-line immunotherapy. METHODS: This retrospective, single-center study enrolled 212 patients. Patients were categorized into the death group, survival group, progressive disease (PD) group, and non-PD (N-PD) group. Prognosis analysis employed Cox regression, Kaplan-Meier (KM) survival curves, and ROC curves. Internal validation was performed using the Bootstrap method and a 10-fold cross-validation approach, and calibration curves were plotted. RESULTS: High IINS was associated with poorly differentiated tumors, stage IV disease, and ≥2 metastases. Patients with PD or death had significantly higher IINS. After adjusting for available confounding factors, a higher IINS remained associated with PD and death. IINS may aid in the prognostic assessments of PD and death within 3 years, with good model performance in internal validation. High-risk patients showed reduced survival. CONCLUSION: Higher IINS correlates with poor 3-year prognosis. Given the limitations of the retrospective, single-center design, the absence of a non-immunotherapy control group, and the failure to adjust for certain key confounding factors, the above conclusions should be regarded as preliminary, hypothesis-generating findings that require external validation through prospective, multicenter studies.
Authors
- Zuo Jian-hui
- Kai Cui
- Wen-jian Liu
Institutions
- First Affiliated Hospital of Anhui Medical University (CN)
Publication Details
- Journal
- Biomarkers
- Published
- 2026-11-16
- DOI
- https://doi.org/10.1080/1354750x.2026.2765438
- Primary Topic
- Inflammatory Biomarkers in Disease Prognosis
- Type
- article
- Field-Weighted Citation Impact
- 0.00